北京奥司他韦近7天销量暴涨237%，热门药库存充足无需抢

Core Insights - The flu activity in Beijing has rapidly increased since November, with significant sales spikes for antiviral medications such as Oseltamivir and Favipiravir, indicating a surge in demand for flu treatments [1][15] - Despite the increased demand for flu medications, pharmacies report that they have sufficient stock to meet consumer needs, alleviating concerns about shortages [1][14] Sales and Demand Trends - Oseltamivir sales have surged by 237% in the past week, while Favipiravir sales increased by 180% [1] - Data from Meituan indicates that sales of flu-specific medications in Beijing have grown over 130% since November, with Oseltamivir and Favipiravir seeing increases of over 85% and 110%, respectively [1][14] Patient Experience and Healthcare Response - Hospitals are experiencing high patient volumes, with over 1,200 patients waiting for flu testing at one facility, reflecting the increased incidence of flu cases [7] - Healthcare facilities are implementing measures to reduce wait times, such as pre-issuing prescriptions for common flu symptoms [2][4] Market Supply and Pricing - Pharmacies report a wide range of prices for Oseltamivir, with domestic versions priced at 108 yuan and imported versions at 228 yuan for a 10-capsule pack, indicating significant price variation [8][14] - Online platforms like Meituan are ensuring adequate supply by collaborating with pharmaceutical companies and maintaining high stock levels, with Oseltamivir coverage at 98% [14][15]